1489 / 1674
Hughes KS, et al. JCO 2013;31:2382-7
•
8% benefit at 10y
•
3% died < breast ca
•
49% died unrelated
Pt selection: EORTC
22922 = 82.3% 10y OS
Less local treatment: where is the limit?
|
|
1489 / 1674
1489 / 1674
Hughes KS, et al. JCO 2013;31:2382-7
•
8% benefit at 10y
•
3% died < breast ca
•
49% died unrelated
Pt selection: EORTC
22922 = 82.3% 10y OS
Less local treatment: where is the limit?